经验

EpimAb Biotherapeutics Raises $120 Million Series C

March 23, 2021

Cooley advised EpimAb Biotherapeutics, a clinical-stage biotech company specializing in bispecific antibody development, on its $120 million Series C financing. China Merchants Bank International and Mirae Asset Financial Group co-led the round, which also included participation by Hony Capital, Cormorant Asset Management and other new investors, as well as existing investors such as Decheng Capital, SDIC Fund and Sherpa Healthcare Partners. EpimAb will use the new capital for the ongoing clinical development of three of its clinical assets and to expand its pipeline of novel bispecific antibodies and other biologics. Partner James Lu led the team advising EpimAb on the financing round.

Related contacts

徐璨
顾问律师, 上海
苏伦嘎
律师, 上海

Related Practices & Industries

InxMed Raises $50 Million Series B

March 10, 2022

Cooley advised InxMed on its $50 million Series B financing. Partner Christina Zhang led the team advising InxMed, which is a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat solid tumors.

CS Capital led the round, with participation from AIHC Fund, Growth Fund and Hosencare Fund, as well as existing investor Ennovation Ventures. InxMed will use the funds to accelerate ongoing clinical trials of IN10018 for multiple cancer types in the US and China, to advance more stroma-targeting pipelines into clinics this year, and to strengthen research and development capabilities in Nanjing, China.

Related contacts

徐璨
顾问律师, 上海
苏伦嘎
律师, 上海

Related Practices & Industries

Hello Group Acquires Happn

September 24, 2025

Cooley advised Hello Group, a leading player in Asia’s online social networking space, on its acquisition of Happn, a French location-based social search mobile and web application that enables users to connect with others based on their proximity and interests.

Read more

Related contacts

徐一林
合伙人, 北京
蔡华
合伙人, 香港
李若木
合伙人, 上海
沈亨达
顾问律师, 上海
苏伦嘎
律师, 上海
Bartholomäus Regenhardt
Associate, 布鲁塞尔
Patrick Van Eecke
合伙人, 布鲁塞尔
Charles Haley
Partner, 帕罗奥图
Hardy Zhou
Associate, 纽约
Athina Gaki
Associate, 布鲁塞尔
Julie Paulino Montejo
Associate, 纽约
Len Jacoby
Partner, 纽约
Christopher Kimball
Partner, 华盛顿特区
John Paul Oleksiuk
Partner, 纽约
Sharon Connaughton
Special Counsel, 华盛顿特区
Dillon Martinson
Special Counsel, 华盛顿特区
Yi Jia Ng
Special Counsel, 新加坡
Anna Caro
Associate, 伦敦
Michael Pelle
Associate, 纽约
姚植洪
律师, 香港
Veronica Cortes
Paralegal Specialist, 纽约

Related Practices & Industries

AusperBio Secures $63 Million Series B2

September 21, 2025

Cooley advised AusperBio, a privately held, clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic hepatitis B (CHB), on its $63 million Series B2 financing.

Read more

Related contacts

Andrew Harline
Partner in Charge – Singapore, 新加坡
沈亨达
顾问律师, 上海
苏伦嘎
律师, 上海
Dr. Madhuri Roy
Partner, 帕罗奥图
魏 乐天
法律顾问, 上海

Related Practices & Industries

Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]

July 25, 2025

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, 帕罗奥图
Rama Padmanabhan
Partner, 圣地亚哥
陆培祥
合伙人, 新加坡
Asa Henin
Partner, 圣地亚哥
Lindsey O'Crump
Associate, 华盛顿特区
Brittany K. Wightman
Associate, 圣地亚哥
Jiqiang Lin
Associate, 纽约
Leina Verrier
Associate, 洛杉矶
Ross Eberly
Partner, 洛杉矶
Stephanie Gentile
Partner, 纽约
Christopher Kimball
Partner, 华盛顿特区
Phil Mitchell
Partner, 纽约
Howard Morse
Senior Counsel, 华盛顿特区
Alessandra Murata
Partner, 帕罗奥图
Jean Park
Partner, 纽约
Aaron Pomeroy
Partner, 科罗拉多
Michelle Garcia Schulman
Partner, 雷斯顿
Ellie Seber
Partner, 洛杉矶
Marty Schenker
Senior Counsel , 旧金山
Mark Windfeld-Hansen
Senior Counsel, 帕罗奥图
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, 布鲁塞尔
Karen Tsai
Special Counsel, 华盛顿特区
王滨
资深顾问, 帕罗奥图
Robert Eisenbach
Of Counsel, 旧金山
Rajdeep Roger Bains
Associate, 圣地亚哥
Julia R. Brinton
Special Counsel, 华盛顿特区
Adrienne Beaudoin Deshmukh
Associate, 雷斯顿
Jeremy M. Exelbert
Associate, 纽约
公泽
律师, 上海
Rick Jantz
Associate, 洛杉矶
Wyatt Kernell
Associate, 科罗拉多
Rebeca Kinslow
Associate, 圣地亚哥
李涵
注册外国律师(纽约), 香港
苏伦嘎
律师, 上海
Novak Topalovic
Associate, 圣地亚哥
Tania Soris
Associate, 华盛顿特区
徐璨
顾问律师, 上海
Sai Yarramalla
Associate, 帕罗奥图
Andy Zachrich
Associate, 旧金山
Patricia Myers
Paralegal Specialist, 科罗拉多
Jake Ironfield
Transactional Quantitative Analyst, 纽约

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.